Impact of pretransplant MRD status on outcome in patients allografted for AML in CR1: results of 2 prospective randomized trials. (A) Results of the USCTN 0901 trial demonstrating the impact of the presence of pretransplant MRD status on outcome in patients receiving a MAC or RIC regimen.¹⁶  (B) Impact of pretransplant MRD status on cumulative incidence of relapse in patients transplanted in the FIGARO trial.¹³  CI, confidence interval; HR, hazard ratio.